companydata.dkcompanydata.dk

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: Financial statements 2015

CVR: 33242840

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS (CVR 33242840) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 9,625,172 and a net result of DKK 459,045 compared with DKK 299,046 the year before. That is an increase of 99.1% compared with the year before. Equity in the 2015 report amounted to DKK 1,304,516. The solvency ratio was 23.7%.

Gross Profit
DKK 9,625,172
Profit/Loss
DKK 459,045
Equity
DKK 1,304,516
Total Assets
DKK 5,496,399

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-9.6M459K1.3M-
2014-4.8M299K845K-
2013-3.8M238K546K-
2012-2.2M145K308K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS: The 2014 annual report is outJul 6, 2015

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS has published its annual report for 2014. Gross profit came to DKK 4,835,014, and the net result was DKK 299,046.

About PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS

PHARMACEUTICAL RESEARCH ASSOCIATES DENMARK ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Thomas Noel O´Leary. The board consists of Thomas Noel O´Leary (chair), John Sheahan and Simon Peter Hollywood. The company is owned by ICON CLINICAL (UK) LIMITED. The company has 49 employees (2026). In 2025, the company reported a gross profit of DKK 61,634,124 and a net result of DKK 3,053,580 compared with DKK 3,554,282 the year before. Equity in the 2025 report amounted to DKK 23,945,884.

Source: annual report 2025, Danish Business Authority